UCB, a global biopharmaceutical company, and XtalPi, a global leader in AI drug discovery, today announced a license agreement ...

Several protein-antibody combinations have shown sensitivities ... The advantages of high sensitivity, multiplex labeling, photo- and chemical stability and the availability of many compatible ...

GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer immunotherapies, today announced today announced its ...

A popular drug for dogs with arthritis may be associated with a variety of potentially severe neurological effects, including ...

Two anti-transferrin receptor (TfR) nanobodies, V H H123 specific for mouse TfR and V H H188 specific for human TfR (huTfR) were used to track transplants non-invasively by PET/CT in mouse models, ...

This study investigates the impact of myenteric neuron-macrophage interactions on postoperative trauma and subsequent ...

Advancement in Nanoparticle-Based NIRF Probes for Precision Visualization in Oncology. Open Access Library Journal, 12, 1-14. doi: 10.4236/oalib.1112471 . Molecular imaging has introduced new ...

PD-L1 not only responds to the cGAS-STING pathway upon DNA damage, but also regulates cGAS-STING to induce inflammation. This ...

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...

StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ – Free Report) in a research report released on Thursday morning. The firm issued a hold rating on the medical research company’s ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...

Nov. 26, 2024 — Healing the gut may be the key to improving long-term recovery in stroke patients, scientists have found. The latest of multiple studies highlights the potential of this novel ...